Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01616303 |
|---|---|
| Brief Title: | A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer |
| First Submitted : | May 30, 2012 |
| First Submitted that Met QC Criteria : | June 7, 2012 |
| First Posted : | June 11, 2012 (Estimate) |
| Certification/Extension First Submitted : | February 7, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | February 11, 2020 |
| Certification/Extension First Posted : | February 17, 2020 |
| Last Update Submitted that Met QC Criteria : | September 11, 2020 |
| Last Update Posted : | September 14, 2020 |